Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New compounds effective against Alzheimer’s disease onset and progression


Drug discovery researchers at Northwestern University have developed a new class of compounds that have the potential to reduce the inflammation of brain cells and the neuron loss associated with Alzheimer’s disease.

The new class of compounds are aminopyridazines. The original compound, called MW01-070C, is used in an injectable form. More recently developed compounds, such as MW01-2-151WH and MW01-5-188WH, can be taken by mouth.

The compounds were designed and synthesized in the laboratory of D. Martin Watterson, J. G. Searle Professor of Molecular Biology and Biochemistry and professor of molecular pharmacology and biological chemistry, Northwestern University Feinberg School of Medicine, using a synthetic chemistry platform developed by the Northwestern Drug Discovery Program for the rapid discovery of new potential therapeutic targets.

The aminopyridazines are targeted for the potential treatment of certain neurodegenerative diseases that are characterized by neuroinflammation and neuronal loss, such as Alzheimer’s disease, Parkinson’s disease, stroke and traumatic brain injury. The compounds inhibit over-activation of glia, important cells of the central nervous system that normally help the body mount a response to injury or developmental change but are overactivated in certain neurodegenerative diseases.

The efficacy and safety of the compounds in an Alzheimer’s disease animal model was evaluated in collaboration with Linda J. Van Eldik, professor of cell and molecular biology at Feinberg.

The scientists described their Alzheimer’s disease drug discovery efforts in recent issues of the Journal of Molecular Neuroscience and the journal Neurobiology of Aging, and a publication that will appear in early 2005 in the journal Current Alzheimer Research. The studies have important implications for future drug development because they provide a proof of concept that targeting neuroinflammation with aminopyridazines is a viable Alzheimer’s disease drug discovery approach that has the potential to modulate disease onset and progression, Van Eldik said.

Deposition of the beta-amyloid plaques and neurofibrillary tangles of Alzheimer’s disease is associated with glial activation, loss of neurons and decline of cognitive function. Long-term or excessive activation of glia increases production of chemokines and cytokines, such as interleukin-1 beta (IL-1b), and oxidative stress-related enzymes, such as a highly active form of nitric oxide synthase (iNOS). The excessive production of the inflammation-related substances can, in turn, contribute to further exacerbation of the disease process.

IL-1b is involved in glial inflammatory and neuronal dysfunction responses, and variants of the IL-1 gene are associated with increased risk for Alzheimer’s disease. The iNOS induced as a result of glial activation generates nitric oxide (NO), which can exist in toxic forms that damage neurons. Therefore, development of new compounds that can modulate these disease-linked biological processes may represent alternative therapeutic approaches and lead to future identification of new drug discovery targets, Van Eldik said.

Van Eldik and co-researchers found that the aminopyridazines inhibited both oxidative and inflammatory cytokine pathways and reduced human amyloid beta (Ab)-induced glial activation in a mouse specially designed to develop many of the hallmarks of Alzheimer’s disease pathology, including neuroinflammation, neuronal and synaptic degeneration and amyloid disposition, often called plaques.

Inhibition of neuroinflammation correlated with a decreased neuron loss, restoration towards control levels of synaptic dysfunction biomarkers in the hippocampus and diminished amyloid plaque deposition. Consistent with the pathology changes, treatment with the aminopyridazines also attenuated behavioral deficits in the mice that are due to injury in the part of the brain called the hippocampus, a region that is gradually destroyed in neurodegenerative diseases such as Alzheimer’s. The Northwestern investigators are now seeking to raise the funding necessary for testing in humans.

Collaborating with Watterson and Van Eldik on this research were Jeffrey M. Craft, a medical scientist predoctoral student in the Drug Discovery Training Program, and Wenhui Hu and Hantamalala Ranay Ranaivo, postdoctoral scholars in the Drug Discovery Training Program.

Elizabeth Crown | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht North and South Cooperation to Combat Tuberculosis
22.03.2018 | Universität Zürich

nachricht Researchers Discover New Anti-Cancer Protein
22.03.2018 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Custom sequences for polymers using visible light

22.03.2018 | Materials Sciences

Scientists develop tiny tooth-mounted sensors that can track what you eat

22.03.2018 | Health and Medicine

Mat baits, hooks and destroys pollutants in water

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>